The 2004 Melanoma Cell Study The only laboratory evidence suggesting anti-cancer effects comes from a single 2004 study reporting that BPC-157 inhibited melanoma cell line growth in culture through VEGF suppression via MAPK kinase pathways
No published randomized, controlled clinical trial has evaluated BPC-157 - including ProHealth's specific formulation - for any human health indication
Your body doesnt make vitamin B12 on its own
Your doctor will decide the correct dose and duration for you depending on your age, body weight and disease condition
Some of our patients may be interested in emerging therapies like BPC-157, especially those undergoing surgeries involving the gastrointestinal tract or experiencing postoperative inflammation
The many blood vessels identified as being activated by specific pathways following a given vessel injury require a regularly applicable therapy, with beneficial effects dependent on, but not limited to, occlusion of a particular vessel (Strbe et al., 2021)